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Signs, symptoms and diagnosis of
necrotizing fasciitis experienced by
survivors and family: a qualitative
Nordic multi-center study
Annette Erichsen Andersson1,2* , Ingrid Egerod3,4, Vibeke E. Knudsen4 and Ann-Mari Fagerdahl5
Abstract
Background: Necrotizing soft tissue infection is the most serious of all soft tissue infections. The patient’s life is
dependent on prompt diagnosis and aggressive treatment. Diagnostic delays are related to increased morbidity
and mortality, and the risk of under- or missed diagnosis is high due to the rarity of the condition. There is a
paucity of knowledge regarding early indications of disease. The aim of the study has thus been to explore
patients’ and families’ experiences of early signs and symptoms and to describe their initial contact with the
healthcare system.
Methods: A qualitative explorative design was used to gain more knowledge about the experience of early signs
and symptoms. Fifty-three participants from three study sites were interviewed. The framework method was used
for data analysis.
Results: Most of the participants experienced treatment delay and contacted healthcare several times before
receiving correct treatment. The experience of illness varied among the participants depending on the duration of
antecedent signs and symptoms. Other important findings included the description of three stages of early disease
progression with increase in symptom intensity. Pain experienced in necrotizing soft tissue infections is particularly
excruciating and unresponsive to pain medication. Other common symptoms were dyspnea, shivering, muscle
weakness, gastrointestinal problems, anxiety, and fear.
Conclusion: Our study adds to the understanding of the lived experience of NSTI by providing in-depth description
of antecedent signs and symptoms precipitating NSTI-diagnosis. We have described diagnostic delay as patient-related,
primary care related, or hospital related and recommend that patient and family narratives should be considered when
diagnosing NSTI to decrease diagnostic delay.
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Background
Necrotizing soft tissue infection (NSTI) is the most serious
and potentially life-threatening of all skin and soft tissue
infections and prompt diagnosis and aggressive treatment
are of utmost importance to save patient lives [1]. NSTIs
include necrotizing cellulitis, necrotizing fasciitis, Fournier’s
gangrene and necrotizing myositis [2]. The condition is rare
with incidence ranging from 0.4 to 7.7 per 100,000 [3–6].
Several studies have shown a rise in incidence over the past
decades [3, 4, 7, 8].
NSTIs typically involve all the soft tissue compartments
from skin to the deeper fascia and muscles. NSTIs affect
most parts of the body, particularly the extremities, peri-
neum and abdominal wall. The disease is generally caused
by microorganisms such as streptococci and staphylococci
that are found on skin and mucosa on healthy individuals.
The causative pathogens attack the subcutaneous tissues
and produce toxins causing ischemia, necrosis and septic
shock that eventually lead to systemic organ failure [1, 3].
The course of the disease is described as rapid, leaving the
patient to deteriorate within hours if not treated correctly.
Rapid, aggressive treatment with surgical debridement
and antibiotic therapy is lifesaving, whereas treatment
with antibiotics alone might be ineffectual due to tissue
necrosis. Additional therapies are given depending on
causative agents, location and type of infection [9]. More
than 50% of the patients require intensive care and mech-
anical ventilation, central line catheters and hemodialysis
[3, 10] as systemic complications and organ failure are
common (40–60%) [3, 11].
Mortality is high despite improved treatment and care
(10–29, 3%) [3, 10–13]. NSTI can be seen in patients of
all ages, with or without comorbidities [14]. Conditions
that have been associated with necrotizing fasciitis in-
clude: diabetes, obesity, renal disease, smoking, alcohol
abuse and immunosuppression [1, 3, 13, 15]. Patients
can acquire NSTI in several ways: the pathogens can be
inoculated into the subcutaneous tissues via injections,
trauma, animal bites, surgical interventions, skin infec-
tions and childbirth, and probably also via hematological
spread in cases with suspected streptococcal pharyngitis
[2, 16]. However, it is not uncommon that no definitive
cause can be found [1, 17].
NSTIs can be described according to anatomical location
or type and number of pathogens involved [18]. Typically, 3
classes of pathogens are described in the literature [2, 16].
Typical signs and symptoms of NSTI are first of all pain,
with other responses including localized edema, erythema,
fever, hypotension, perspiration, skin necrosis and crepitus
[1, 13]. In the early stages, the risk of under-diagnosis is
high since the condition is rare. For example, one study
demonstrated that only 14% of patients with NSTI were
properly diagnosed on admission [17]. Delays in diagnosis
increase the rates of morbidity and mortality [9, 19]. Studies
are still lacking that describe early signs and symptoms of
NSTI from the perspective of patient and family. This type
of study can potentially contribute new knowledge con-
cerning the onset and dissemination of NSTIs. The aim of
our study was to explore the patient and family experience
of early signs and symptoms of NSTI in NSTI survivors
and to describe their initial contact with the healthcare
system, in order to delineate strengths and weaknesses in
care provided.
Methods
Study design
The study is embedded in a larger EU study, the
INFECT-study, aiming to understanding the pathophysi-
ology of NF and other NSTIs. As a contrast to the
INFECT-study, we chose in the present study (the
P-INFECT-study) to apply a qualitative explorative de-
sign to gain more knowledge about the experience of
early signs and symptoms of NSTI in patients and their
families [20]. From the onset, the study was planned and
designed in close cooperation with NSTI survivor Kim
Andersson and his wife (patient and public involve-
ment). The present study is the third in a planned series
of five qualitative studies investigating NSTI from the
perspective of patients and their families (ClinicalTrials.-
gov Identifier: NCT02169128). Our first paper provided
a template to inform the patient and family of a typical
NSTI-trajectory and what to expect [20]. Our second
paper described family caregivers’ coping strategies in
ICU, in the ward, and after returning home [21].
Participants and selection
Patients and families were recruited from three centers
where treatment of NSTI was centralized a national level
in Sweden and Denmark. In the INFECT study, NSTI was
confirmed by perioperative tissue characteristics, observed
by the surgeon. Diagnosis was based on signs of necrotic
soft tissue with widespread undermining of the surround-
ing tissue [22]. In the present study, the P-INFECT study,
we screened discharged patients with confirmed NSTI for
eligibility using the following criteria: NSTI diagnosis, age
≥ 18, and provision of written informed consent to partici-
pate in the study. Exclusion criteria were dementia or
severe psychiatric illness.
All participants were provided with written and verbal
information regarding this qualitative study in relation to
the INFECT study. Close family was defined by the
patients and included husband/wife, partner, sibling, chil-
dren and close friend. At 6 months after diagnosis the par-
ticipants received a letter with study information and we
asked both patient and family to confirm that they agreed
to be interviewed. After confirmation, the participants
were contacted by phone to decide on the location for the
interview. The participants were included consecutively,
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however the intention was to achieve a heterogeneous
group in terms of age and sex in order to obtain as rich
data as possible. It was estimated that approximately 10
patients and 10 close family members at each study site
would be an appropriate sample size to ensure variation of
the phenomenon in focus and to achieve the intended
purpose [23]. Data saturation was assessed during data
collection to determine the final sample size.
Context of the study
The healthcare systems in Sweden and Denmark are
funded by taxes. In Sweden the patient pays approx. EUR
30 for an emergency room visit and EUR 20 for a visit to
the General Practitioner, GP. There is no charge in
Denmark. Primary service centres and hospitals provide
multidisciplinary care, and out-of-hours (OOH) service is
available to handle urgent and emergent illness when the
GP is unavailable. OOH call handlers provide immediate
support to the caller and triage the patient to the type of
service needed.
Data collection
Data were collected from August 2014 to March 2016
using in-depth semi-structured individual interviews to
allow the participants’ experiences of and perspectives on
NSTI, care and treatment to emerge [24]. After consulting
our patient representative Mr. Andersson and family, we
decided to conduct the interviews 6 months after diagno-
sis. This would allow the participants to come to terms
with the initial shock of diagnosis and early treatment. We
preferred to conduct the interviews face-to-face, but if this
was not feasible some interviews could be conducted by
telephone. The interviews were carried out by investiga-
tors with experience of caring for patients with NSTI in
the acute setting.
Our main question was: “Please tell me: how did you
experience your illness?” To ensure that we understood
the participants’ responses, we posed clarifying questions
during the interview. If necessary, additional questions
were asked regarding early signs and symptoms and the
first contacts with healthcare. All interviews were digitally
recorded and transcribed verbatim. Demographic data
were obtained from medical charts.
Data analysis
The interviews were analyzed using the framework
method [25] that allowed for the development of themes
from the narratives of the participants as well as research
questions. The analytic process involved five interrelated
key stages, see Table 1. Several measures were taken to
ensure the trustworthiness of our study [26] (chapter 9).
Tentative themes were cross-validated by 25% of the
informants during a post-interview meeting. To enhance
creditability, the final themes and sub-themes were chal-
lenged by searching data for alternative themes, divergent
patterns and rival explanations. In addition, findings were
discussed between all the researchers until consensus on
interpretation was reached. To enhance credibility, the
results are supported by representative quotes.
Results
Demographics
We conducted 53 interviews at the three study sites: 10
patients and 9 family members in Gothenburg (SU), 8
patients and 6 family members in Stockholm (KI), and 10
patients and 9 family members in Copenhagen (RH).
Thus, we interviewed 28 patients, 18 men and 10 women
29–90 years of age. The infection was located in their
extremities (n = 16), groin/genitals and lower abdomen (n
= 7), face and throat (n = 3), and back (lateral dorsi) (n =
2). Tissue samples showed growth of different types of
streptococci, Group A being the most prevalent (n = 22)
followed by groups G and B. Poly-microbial infection was
found in 7 cases including growth of Staphylococcus aur-
eus and Staphylococcus epidermis.
Qualitative findings
Our analysis covered the time from initial signs and
symptoms to diagnosis of NSTI. We identified three
themes describing the experience of patient and family
in the early stage of illness as shown in Table 2: Duration
Table 1 Analytical steps in the Framework method
Analytical steps Our process of analysis
Familiarization All researchers read transcripts and listened to tape recordings to become familiar with the data.
Identification of a thematic
framework
Two researchers independently coded the first transcript before developing a tentative coding
framework using a priori research questions and emergent issues. All researchers contributed
feedback and adjustments.
Indexing The thematic framework was applied to each transcript and the texts were coded accordingly,
e.g. signs and symptoms, etc.
Charting Matrixes were created for every key subject area. Data from each case and code were then
charted within the themes.
Mapping and interpretation Each matrix was analyzed inductively and data were compared to detect similarities, differences
and patterns.
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of disease onset, Stages of symptom severity, and Types
of treatment delay.
Duration of antecedent symptoms
The experience of illness varied among the participants
in our study depending on the perceived duration of
disease onset from long to short inception. We defined
long inception as a period of more than 7 days with
gradual escalation of antecedent signs and symptoms be-
fore life-threatening diagnosis. This was often associated
with a month of malaise with recurrent streptococcal
throat infections at home or at work, perhaps increasing
the patient’s susceptibility for serious disease. Medium
inception lasted 3–7 days, with signs and symptoms
gradually emerging and increasing in intensity. Short
inception lasted 1–2 days, with antecedent signs and
symptoms rapidly progressing to severe impairment of
the patient’s mental and physical state. In our sample,11
patients experienced a short inception, 9 described a
moderate inception, 6 described a long inception, and
one was undetermined.
Case description of long inception
A otherwise healthy person experienced a sore throat
recurrently during early spring and felt unwell for some
weeks with a fluctuating temperature:
“In the beginning of May I felt increasingly crummy.
I couldn’t exactly describe what was wrong but there
were no signs on my body that indicated what was
wrong”.
The last 2 weeks before diagnosis the person felt increas-
ingly worse and finally the symptoms became so intense
that they could no longer be ignored:
“Then one day at the end of May I felt that my body
had no more resistance … it was like a really bad case
of the flu, and my leg started to ache”.
The pain increased and finally became unbearable: “much
worse than being in labor”. Her husband drove her to the
emergency department (ED), where she was finally assessed
and treated. At this time, person was confused and dizzy
with pain:
“After blood tests, they diagnosed me with severe
sepsis and I have read my chart saying that just
2-3 hours later, I suffered total organ failure”.
Case description of moderate inception
On Monday, a man started to feel poorly. On Wednesday
he woke up in the morning with a sore throat and
contacted the medical on-call service. The call handler
advised him that he was okay if he had no white spots in
his throat. On Thursday, the throat was more painful and
he had a hard time swallowing painkillers, but still no vis-
ible white spots. On Saturday he ran a fever and felt pain
in his thigh. He was unable to swallow and needed help.
His wife contacted the medical on-call service and the call
handler recommended paracetamol (acetaminophen).
After a few hours, his wife called again because the medi-
cine gave no relief and they both feared that something
was terribly wrong. His wife made a doctor’s appointment
and tests revealed strep throat with elevated levels of
C-reactive protein (CRP). He complained to a nurse of
pain in his thigh, but the nurse said not to worry, because
there was no swelling. He returned home with a prescrip-
tion for antibiotics. On Sunday his throat felt better, but
the pain in his leg had gotten worse:
“I had a really bad feeling, it was scary and I felt that
I no longer had control over the situation”.
He became nauseated and was unable to move due to
severe pain in his leg. He contacted the medical on-call
service and got a doctor’s appointment. At this point his
thigh had swollen rapidly over the course of few hours.
A new set of tests showed a CRP over 200 and he was
sent to the hospital. An ambulance was not dispatched
at this time:
“I had to almost carry him into the car. At the
hospital, they immediately understood that something
was wrong and we were both taken care of”.
Case description of short inception
A woman was relaxing in her garden after a day at the
beach. Suddenly she felt pain in her lower leg, and shortly
after the leg turned red. Within a few hours of the first
signs and symptoms, the pain and discomfort escalated
and she asked her son to help her to bed. Her son
contacted the medical on-call service and was advised to
give ibuprofen and wait: “It will pass”. The pain became
Table 2 Themes and sub-themes
Themes Sub-themes
Duration of antecedent
signs and symptoms
Long inception: More than 7 days
Moderate inception: 3–7 days
Short inception: 1–2 days
Stages of symptom severity Stage I. Lingering symptoms
Stage II. Progressive symptoms
Stage III. Unbearable symptoms
Types of diagnostic delay Patient-related delay
Primary care related delay
Hospital related delay
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unbearable and the medical on-call service was contacted
another two times:
“I panicked, I have never experienced such pain before,
I asked for an ambulance, but the doctor said: ‘do you
really want to burden the healthcare system with the
extra expenses?’”
In the evening she had deteriorated to the point that the
family decided to take her to the nearest hospital:
“At first they said there was nothing wrong with me –
all the blood tests were okay. I was placed in the
hallway of the hospital when an orderly from the ED
discovered something was very wrong. He quickly got
me a physician…I don’t remember anything after that”
Stages of symptom severity
The narratives from patients and their family members
provided a good picture of the disease manifestations.
We present these in three stages of symptom severity
that appear differently depending on the duration of
disease onset. In the first stage the patients described
flu-like symptoms that could last for a month during
long inception. “My muscles were sore like after exercise”.
In the second stage, most patients and family started to
feel that “something was seriously wrong”. The spectrum
of symptoms included pain, malaise, shivering, fever and
nausea. The intensity of pain escalated and most of the
patients became bedridden due to muscular weakness.
Patient and family became anxious as the disease felt
life-threatening: “It was a scary feeling of losing
control”… “I felt really bad and started to get the feeling
that I might die”. The patients became so weak that they
were unable to move about. Both patients and their
families realized that something was wrong. The third
stage included intensified pain, fear and anxiety with
confusion, dizziness or fainting. Memory of this stage
was often fragmented although some patients were able
to recount what had happened: “The nurse couldn’t
measure my blood pressure and said that there must be
something wrong with the machine”… “At the ED the
doctor cut my arm … I couldn’t feel this even though I
was not anesthetized … my arm was so swollen”. One
patient said that when her condition was finally taken
seriously, the last thing she recalled before passing out
was the nurse calling for adrenaline and the doctor com-
pressing the fluid bags.
The signs and symptoms of infection described by the
patients are displayed in Table 3. Symptoms of disease
were present even during the first stage whereas signs
of illness were typically present in the second and third
stages. Two common features emerged: the level of
pain was worse than anything previously experienced,
and painkillers had no effect. The patients were unable
to articulate their sensation of pain: “The pain in-
creased … it became unbearable and I was just scream-
ing from pain when I came to the hospital…” … “The
pain was indescribable, so violent and completely ex-
treme”. Uniquely for the patients (6 men and 1 woman)
with an infection in the genitals/groin, the infection
presented itself as a boil or a small abscess. The pain
intensity in this area was not described as unbearable.
Types of diagnostic delay
Most of the participants experienced diagnostic delay. We
have categorized delay as related to the patient, primary
care and hospital care.
Diagnostic delay related to the patient
Patient/family related delays were uncommon, but delay
was seen in a few of our participants for the following
reasons: too weak to visit the ED, expecting it to get
better, forgetting an appointment with the GP or the
regular GP unavailable. Initial contact was typically to
the on-call or medical service. Otherwise the patients
usually made an appointment with the primary care cen-
ter or their GP.
Diagnostic delay related to primary care
According to the narratives, the main reasons for nurse/
physician delays were:
1. Misdiagnosis such as the flu, a sore throat or a
stomach virus.
2. Misdiagnosis related to lack of acknowledgment
of the patient’s or family’s complaints: “I felt
uneasy, weak, dizzy, had no appetite and had
high fever and also heart palpitations and
couldn’t move… we called the primary care
center and medical on-call service several times
over the course of 3 days…” Wife: “He was not
himself, he was in such pain and throwing up
but they all said that it was completely normal
to feel this way…”
Patients that contacted the primary care center were
advised to go to the hospital, but an ambulance was not
dispatched. Among our participants, 18 arrived at the hos-
pital by car or public transportation, 6 by ambulance, and
two unspecified. Three patients requested an ambulance,
but this was denied. One patient waited for 4 h for trans-
portation and finally reached the hospital in a critical state:
[Family] “When he arrived at the hospital he had
no blood pressure … they thought that there must
be something wrong with the machine….”
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The families were expected to drive the patient to the
nearest hospital, even if the patient was unable to walk:
“She supported me all the way to the car, put me
in the front seat, fastened my seatbelt, when I just
tumbled over to her side”.
“I was in extreme pain, my heart rate was over 170,
it was difficult to move and to get into the car….”
Diagnostic delay related to the hospital
Delays at the hospital were usually due to waiting in the
ED. Patients waited for 2–8 h if the triage nurse failed to
recognize the gravity of the situation:
“There was no one in the ED checking on him for 3
hours… I could see he was just getting worse and
worse…”.
Other reasons for hospital related diagnostic delay were
e.g. premature diagnosis (erysipelas, hepatitis, kidney
failure, gallbladder rupture, heart failure) and missed or
overlooked important clues towards correct diagnosis.
Several family members described their despair when
unable to draw attention to what they thought was
important or wrong. Many participants described how
they were not taken seriously, and how this led to
unnecessary delays:
“He could not sit so I tried to support him ... I
had to ask for a bed and then he had to lie there
in a hallway. He was so thirsty and shivering and
in such pain; I tucked him in with my jacket and
had to ask the nurses to give him painkillers…
they said that a doctor would check on him in
some hours … He was so afraid, I asked the nurse
assistant if he could get a sedative to ease this
terrible experience … but she answered that this
was not so bad….”
“I said to a nurse [at the ED] ‘please, please can
someone look at my husband’s foot’…but no, there
was no doctor there that had the time”.
Discussion
The aim of our study was to explore the patient and
family experience of early signs and symptoms of NSTI
and to describe the initial contact with the healthcare
system. Our main findings were the detailed descriptions
of long, moderate and short inception, providing an
illustration of the variation in duration of antecedent
signs and symptoms. Other important findings included
the description of three stages of early disease progres-
sion with increase in symptom intensity. Finally, our
study suggested that the level of pain experienced in
NSTI is particularly excruciating and unresponsive to
over-the-counter pain medications.
Our study refutes the typical description of disease
progression in the literature as always rapid [1, 3]. Ac-
cording to the patients, the antecedent signs and symp-
toms prolonged the disease experience, albeit the disease
progression was in fact rapid after diagnosis of NSTI.
The varying inception periods and the subjective symp-
toms were described in detail by the participants in our
study. They had a strong feeling that something was very
wrong when patients developed symptoms such as dys-
pnea, shivering, muscle weakness, gastrointestinal prob-
lems, and altered mental status.
The patients in our study all experienced a number of
symptoms as a precursor to NSTI. Pain is the main
symptom described in the current literature [1, 2, 16],
albeit it is not considered a diagnostic variable because it
is non-specific. Current recommendations rely on quanti-
fiable signs and late clinical findings such as the “positive
fingers test” (probing fascia to see if tissue dissects), dish-
washer pus and/or grey necrotic tissue [16, 27, 28]. Wong
et al. [29] have developed a risk index score, Laboratory
Risk Indicator for Necrotizing infections (LRINEC) to dis-
tinguish NSTI from non-necrotizing infections. The NSTI
guidelines, however, state that the LRINEC score lacks the
sensitivity to be useful [2]. In contrast, a recent systematic
review demonstrated a positive correlation between LRI-
NEC score and a true diagnosis and concluded that the
scoring system is a useful clinical determinant in the diag-
nosis of NSTI [30]. Our study suggests that the LRINEC
score might not be relevant in the early detection of
disease since abnormal values are also late signs of severe
infections. Patient reported symptoms are often described
before quantifiable signs of infection, presenting an argu-
ment for the inclusion of the patient’s narrative as part of
Table 3 Patient experience of symptoms and family experience
of signs r/t NSTI
Symptoms (reported by patient) Signs (reported by
patient and family)
Pain (n = 20)
Feeling of being unwell
Chills or shivering
Flu-like symptoms, aching body
Nausea
Decreased mobility
Tired, fatigued, weak
Abnormal thirst
Feeling that something is very wrong
Anxiety, fear, panic
Difficulty breathing
Dizzy or confused
Apathy or listlessness
High fever (n = 14)
Local swelling (n = 13)
Red or blue skin (n = 12)
Vomiting or diarrhea (n = 9)
Boil or abscess (n = 7)
Chills or fever (n = 5)
Rapid heart rate (n = 3)
Local heat (n = 2)
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the diagnostic process. We suggest that patient and family
narratives and description of antecedent signs and symp-
toms should be included more systematically in the pri-
mary care and emergency settings. This would make sense
as emerging studies suggest that patient participation
might prevent adverse events [31].
Other research has focused on the diagnostic value of
symptoms. A study by Edman-Wallér et al. [32] shows
that altered mental status and dyspnea are symptoms as-
sociated with severe sepsis. As diagnosis of NSTI is and
probably will remain difficult, a structured use of com-
mon symptoms in combination with signs seems to be a
promising way towards reducing delays. It is important
to stress that experiencing NSTI is traumatizing, and
not listening to patients or family members, neglecting
them or not involving them in the care might increase
patient suffering and diagnosis delay. On the other hand,
being taken seriously and met with empathy and respect
seems to ease the emotional pain.
Our study illustrates how delays occur during the early
stages of NSTI for various reasons. Some delays were
patient related and are, perhaps, difficult to change.
Other delays were seen within the healthcare system
where there might be room for improvement. We be-
lieve that the patient and family perspective was in some
cases ignored when the patient presented symptoms of
infection. It was surprising that patients with very high
CRP and signs of severe illness at primary care centers
were told to make their own way to the ED instead of
dispatching an ambulance. We assume the severity of
illness was not recognized.
Our findings demonstrate that patients with NSTI
risked misdiagnosis when healthcare professionals
prematurely decided on an incorrect diagnosis. NSTI
requires quick diagnosis and treatment, but premature
diagnosis might prevent correct diagnosis when more
data are available [30]. It is also common to go for the
most obvious and overlook other explanations, as we
have demonstrated in several of our cases. However,
specific training strategies exist that can be applied to
minimize diagnostic error, including awareness of cog-
nitive and contextual factors that predispose for diag-
nostic errors, and simulation training of diagnostic
reasoning [33]. Aside from that, there seems to be a
need for better basic knowledge about the diverse
manifestations of NSTI among nurses and physicians in
primary healthcare but also among health professionals
working in the ED. We hope our findings will increase
awareness of antecedent signs and symptoms of NSTI
and subsequently prevent misdiagnosis and diagnostic
delay. We suggest the integration of patient reported
symptoms and guidelines with objective measures.
There is a need for studies describing whether symp-
toms and symptom clusters can assist diagnosis and
prevent fatal outcomes. We believe that a campaign like
the Surviving Sepsis Campaign (http://www.survivingsep-
sis.org) is a good example of an initiative that provides
guidelines, educational material and recommendation for
implementation that could inspire help to spread aware-
ness and knowledge about NSTI in the society.
Strengths and limitations
The credibility of our study was increased by the adoption
of well-established research methods and investigator tri-
angulation. We encouraged the participants to be frank in
their responses and used iterative questioning to increase
transparency. As such, our study generated important new
knowledge based on subjective experiences of NSTI that
cannot be measured quantitatively. A qualitative design
does not allow for generalizations, thus the findings
cannot be applied directly to a wider population or to
other settings and populations. However, we assume that
there is transferability to other similar settings. Our study
generated hypotheses that could be tested in a larger-scale
investigation with a quantitative design to enable
generalization. We realize there is potential survivor-bias
in our study and we acknowledge that non-survivors’
experiences might differ from our findings. Furthermore,
as our investigation was limited to streptococcal, microbial
and polymicrobial infections, future studies exploring the
early development in relation to anaerobe microorganisms
could contribute with important information. Recall-bias
is a limitation in qualitative interview studies [34]. We had
to balance the scientific advantage of early interviewing
with the ethical disadvantages of premature infringement
on the participants. We discussed this matter with the
NSTI-survivor involved in the planning of the study and
decided on interviewing about 6 months post diagnosis.
We increased the trustworthiness of our study by inter-
viewing both patient and family.
Conclusion
Our study adds to the understanding of the lived experi-
ence of NSTI by providing in-depth description of ante-
cedent signs and symptoms precipitating NSTI-diagnosis.
Inception periods vary from over a week to less than a
day, while symptoms escalate in severity increasing
frustration and fear in patient and family. We described
diagnostic delay as patient-related, primary care related, or
hospital related and recommend that patient and family
narratives should be considered when diagnosing NSTI to
decrease diagnostic delay.
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